HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,531 | +30.5% | 616 | +23.2% | 0.00% | 0.0% |
| Q2 2023 | $18,035 | -5.6% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $19,095 | +63550.0% | 500 | -4.4% | 0.00% | -50.0% |
| Q4 2022 | $30 | -99.9% | 523 | -9.7% | 0.00% | +100.0% |
| Q3 2022 | $23,000 | -99.7% | 579 | -99.6% | 0.00% | -99.7% |
| Q2 2022 | $7,180,000 | +8764.2% | 163,186 | +8006.6% | 0.30% | +14700.0% |
| Q4 2021 | $81,000 | +3950.0% | 2,013 | +3200.0% | 0.00% | – |
| Q3 2021 | $2,000 | -97.6% | 61 | -97.0% | 0.00% | -100.0% |
| Q1 2021 | $83,000 | – | 2,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |